Cargando…
New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells
Inhibitor of Apoptosis Proteins (IAPs) are validated targets for cancer therapy, and the deregulation of their activities within the NF-κB pathway correlates with chemoresistance events, even after treatment with IAPs-antagonists in the clinic (Smac-mimetics). The molecule FC2 was identified as a NF...
Autores principales: | Fiore, Michele, Mosconi, Michele, Bonì, Francesco, Parodi, Alice, Salis, Annalisa, Tasso, Bruno, Mastrangelo, Eloise, Millo, Enrico, Cossu, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823934/ https://www.ncbi.nlm.nih.gov/pubmed/36615638 http://dx.doi.org/10.3390/molecules28010446 |
Ejemplares similares
-
Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment
por: Cossu, Federica, et al.
Publicado: (2019) -
Structure‐Activity Relationship of NF023 Derivatives Binding to XIAP‐BIR1
por: Sorrentino, Luca, et al.
Publicado: (2019) -
The structure of XIAP BIR2: understanding the selectivity of the BIR domains
por: Lukacs, Christine, et al.
Publicado: (2013) -
Benzodiazepinones: Drug withdrawal symptoms: 3 case reports
Publicado: (2022) -
Evrenin Sırları bir bir çözülecek
Publicado: (2008)